Research platform targeting the CEP-CEPR1 signalling pathway to enhance nitrogen use efficiency and crop yield. Misregulation of pathway components significantly impacts nitrogen uptake and seed development, offering targets to reduce fertiliser costs and environmental impact in agriculture.
This research program targets a critical bottleneck in global agriculture: inefficient nitrogen use. Excessive nitrogen fertiliser application costs up to $2 trillion per year globally while harming the environment. The team has identified key signalling components, including CEP peptides and their receptor CEPR1, that regulate both nitrogen demand signalling and plant reproduction. Manipulating this pathway offers a route to improving nitrogen use efficiency and increasing crop yield, addressing both economic and sustainability challenges in agriculture.
Core pathway components:
Key findings:
Validation approach:
The research is at an early-to-mid stage of development. Key pathway components have been identified and characterised through mutant analysis and transcriptomic studies, demonstrating significant yield impacts. Future work will define gene networks, mode of action, and pathway interactions to enable practical manipulation of nitrogen use and crop yield. The technology offers potential applications in crop breeding and agricultural biotechnology for reducing fertiliser dependence.
The University of Auckland is a comprehensive public research university—New Zealand’s largest—serving a broad research portfolio and a large, diverse student body. Research is anchored across adjacent city and Newmarket sites with shared core facilities, pilot lines, and test halls; the health campus sits beside major Auckland hospitals, enabling clinical translation. UniServices, the university’s commercialization company, provides a single front door for contracting, IP management, and venture formation, with experienced teams to deliver multi‑party programs. Research is supported by competitive funding from New Zealand’s major agencies and international sponsors, including programs administered by MBIE, the Health Research Council, and the Marsden Fund. Dedicated tech transfer, incubator links, and prototyping resources help partners move from discovery to pilot and scale‑up.